These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 1617635

  • 1. Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells.
    Lestavel-Delattre S, Martin-Nizard F, Clavey V, Testard P, Favre G, Doualin G, Houssaini HS, Bard JM, Duriez P, Delbart C.
    Cancer Res; 1992 Jul 01; 52(13):3629-35. PubMed ID: 1617635
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
    Al-Haideri M, Goldberg IJ, Galeano NF, Gleeson A, Vogel T, Gorecki M, Sturley SL, Deckelbaum RJ.
    Biochemistry; 1997 Oct 21; 36(42):12766-72. PubMed ID: 9335533
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. LDL-mediated drug targeting.
    de Smidt PC, van Berkel TJ.
    Crit Rev Ther Drug Carrier Syst; 1990 Oct 21; 7(2):99-120. PubMed ID: 2272100
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake.
    Chung NS, Wasan KM.
    Adv Drug Deliv Rev; 2004 May 07; 56(9):1315-34. PubMed ID: 15109771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice.
    Masquelier M, Vitols S, Peterson C.
    Cancer Res; 1986 Aug 07; 46(8):3842-7. PubMed ID: 3731059
    [Abstract] [Full Text] [Related]

  • 18. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity.
    Noto D, Rizzo M, Barbagallo CM, Cefalù AB, Verde AL, Fayer F, Notarbartolo A, Averna MR.
    Metabolism; 2006 Oct 07; 55(10):1308-16. PubMed ID: 16979400
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.